CWM
BIOC

Castle Wealth Management’s Biocept, Inc. BIOC Stock Holding History

Castle Wealth Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed -$1K – 710
2022
Q3 		$1K Hold
45
– – ﹤0.01% 664
2022
Q2 		$1K Buy
+45
New +$2.05K ﹤0.01% 664

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Castle Wealth Management's BIOC Position: Q4 2022 in Review

Castle Wealth Management sold out of Biocept, Inc. (BIOC) in Q4 2022, closing a stake of 45 shares — an estimated $1K sold.

Castle Wealth Management first reported a position in BIOC in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

  • Castle Wealth Management reported no remaining Biocept, Inc. position as of Q4 2022 after selling out during the quarter.
  • Castle Wealth Management sold 45 Biocept, Inc. shares in Q4 2022, an estimated $1K.
  • Castle Wealth Management first reported a position in Biocept, Inc. in Q2 2022 and held it in 2 quarters.
  • Castle Wealth Management's Biocept, Inc. position peaked at $1K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.